European Union · Question · QUESTION_WRITTEN
E-10-2025-001881
Revocation of the authorization of the drug Ocaliva for primary biliary cholangitis
Introduced
12 May 2025
Last action
—
Status
answered
Sponsors
—
Subjects
Discovery layer
Source updated
3 July 2025
Records
Official question E-10-2025-001881 from European Union at European Parliament. Dated 12 May 2025. Status: answered.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
5 official files
Withdrawal of authorisation of the drug Ocaliva for treatment of primary biliary cholangitis
Withdrawal of authorisation of the drug Ocaliva for treatment of primary biliary cholangitis
QUESTION_WRITTEN · EN · 19 May 2025
Withdrawal of authorisation of the drug Ocaliva for treatment of primary biliary cholangitis
QUESTION_WRITTEN · EN · 19 May 2025
Answer
QUESTION_WRITTEN_ANSWER · 3 July 2025
Revoca dell'autorizzazione del farmaco Ocaliva per la colangite biliare primitiva
QUESTION_WRITTEN · IT · 19 May 2025
Revoca dell'autorizzazione del farmaco Ocaliva per la colangite biliare primitiva
QUESTION_WRITTEN · IT · 19 May 2025
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.